Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Seretide Evohaler

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 264 No 7102p970
June 24, 2000 Products

Prescription products

Seretide Evohaler

Seretide EvohalerGlaxo Wellcome has received approval from the Medicines Control Agency to market Seretide (fluticasone propionate plus salmeterol xinafoate) in a metered dose inhaler delivery device. Seretide Evohaler is CFC-free and will be available in the following three strengths: Seretide 50 (salmeterol [as xinafoate] 25µg, fluticasone propionate 50µg), Seretide 125 (salmeterol [as xinafoate] 25µg, fluticasone propionate 125µg) and Seretide 250 (salmeterol [as xinafoate] 25µg, fluticasone propionate 250µg). Seretide Evohaler is licensed for adults and adolescents aged 12 years and over. Each metered dose inhaler will contain 120 doses. The company says that the product should be available by the end of July. Prices to be confirmed.

Citation: The Pharmaceutical Journal URI: 20001994

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.